Role of the nuclear factor kappa Beta ligand (RANKL) in osteoarthritis and oseteoclastogenesis in thoroughbred horses. Use of anti-inflammatory drugs.

Authors

  • Luis De Negri Núcleo de Investigaciones Aplicadas en Ciencias Veterinarias y Agronómicas (NIAVA), Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago
  • Luis Olguin Núcleo de Investigaciones Aplicadas en Ciencias Veterinarias y Agronómicas (NIAVA), Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago
  • Leonardo Pavez Núcleo de Investigaciones Aplicadas en Ciencias Veterinarias y Agronómicas (NIAVA), Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago

DOI:

https://doi.org/10.15381/rivep.v32i2.20009

Keywords:

RANKL, osteoarthritis, equine, osteoclastogenesis, inflammation

Abstract

Osteoarthritis (OA) is one of the main conditions that affects the performance of sports horses. Early diagnosis of the disease is relevant in its clinical and therapeutic management. The evidence shows that this process has a clear relationship between osteoclasts and immune cells sharing molecules such as cytokines, receptors, signaling molecules and transcription factors that influence each other where they play a crucial role in both pathological and physiological bone resorption. The role of the nuclear receptor activator ligand-KB (RANKL) is described as one of the most relevant cytokines that induce osteoclastogenesis.

Downloads

Download data is not yet available.

Downloads

Published

2021-04-22

Issue

Section

Artículo de revisión

How to Cite

De Negri, L., Olguin, L., & Pavez, L. (2021). Role of the nuclear factor kappa Beta ligand (RANKL) in osteoarthritis and oseteoclastogenesis in thoroughbred horses. Use of anti-inflammatory drugs. Revista De Investigaciones Veterinarias Del Perú, 32(2), e20009. https://doi.org/10.15381/rivep.v32i2.20009